302 related articles for article (PubMed ID: 34937)
21. The role of the capsular polysaccharide in the activation of the alternative pathway by the pneumococcus.
Winkelstein JA; Bocchini JA; Schiffman G
J Immunol; 1976 Feb; 116(2):367-70. PubMed ID: 2634
[TBL] [Abstract][Full Text] [Related]
22. Bactericidal and opsonic activities of normal sheep serum against gram-negative bacteria.
Mittal KR; Ingram DG
Am J Vet Res; 1975 Aug; 36(08):1189-93. PubMed ID: 1098532
[TBL] [Abstract][Full Text] [Related]
23. Complement activation by pneumococci associated with acute otitis media.
Prellner K
Acta Pathol Microbiol Scand C; 1979 Jun; 87C(3):213-6. PubMed ID: 39420
[TBL] [Abstract][Full Text] [Related]
24. Serum heat-labile opsonins in systemic lupus erythematosus.
Jasin HE; Orozco JH; Ziff M
J Clin Invest; 1974 Feb; 53(2):343-53. PubMed ID: 11344546
[TBL] [Abstract][Full Text] [Related]
25. Alternative complement pathway-dependent ingestion of fluolite particles by human granulocytes.
Arnaout MA; Luscinskas FW; Lionetti FJ; Alper CA; Valeri CR
J Immunol; 1981 Jul; 127(1):278-81. PubMed ID: 6787126
[TBL] [Abstract][Full Text] [Related]
26. Pneumococcal intracellular killing is abolished by polysaccharide despite serum complement activity.
Schweinle JE
Infect Immun; 1986 Dec; 54(3):876-81. PubMed ID: 3781629
[TBL] [Abstract][Full Text] [Related]
27. Effect of Haemophilus influenzae type b lipopolysaccharide on complement activation and polymorphonuclear leukocyte function.
Inzana TJ; Tosi MF; Kaplan SL; Anderson DC; Mason EO; Williams RP
Pediatr Res; 1987 Dec; 22(6):659-66. PubMed ID: 3324033
[TBL] [Abstract][Full Text] [Related]
28. Alterations in serum opsonic activity and complement levels in pneumococcal disease.
Giebink GS; Dee TH; Kim Y; Quie PG
Infect Immun; 1980 Sep; 29(3):1062-6. PubMed ID: 6903559
[TBL] [Abstract][Full Text] [Related]
29. Opsonization and phagocytosis of mucoid and non-mucoid Pseudomonas aeruginosa strains.
Meshulam T; Verbrugh HA; Verhoef J
Eur J Clin Microbiol; 1982 Apr; 1(2):112-7. PubMed ID: 6816585
[TBL] [Abstract][Full Text] [Related]
30. Opsonization and antibodies to capsular and cell wall polysaccharides of Streptococcus pneumoniae.
Vitharsson G; Jónsdóttir I; Jónsson S; Valdimarsson H
J Infect Dis; 1994 Sep; 170(3):592-9. PubMed ID: 8077716
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of the opsonic requirements for phagocytosis of Streptococcus pneumoniae serotypes VII, XIV, and XIX by chemiluminescence assay.
Matthay KK; Mentzer WC; Wara DW; Preisler HK; Lameris NB; Ammann AJ
Infect Immun; 1981 Jan; 31(1):228-35. PubMed ID: 7216447
[TBL] [Abstract][Full Text] [Related]
32. Lack of a requirement for the Fc region of IgG in restoring pneumococcal opsonization via the alternative complement pathway in sickle cell disease.
Bjornson AB; Lobel JS
J Infect Dis; 1986 Nov; 154(5):760-9. PubMed ID: 3095435
[TBL] [Abstract][Full Text] [Related]
33. Peptide mimics of two pneumococcal capsular polysaccharide serotypes (6B and 9V) protect mice from a lethal challenge with Streptococcus pneumoniae.
Smith CM; Lo Passo C; Scuderi A; Kolberg J; Baxendale H; Goldblatt D; Oggioni MR; Felici F; Andrew PW
Eur J Immunol; 2009 Jun; 39(6):1527-35. PubMed ID: 19499518
[TBL] [Abstract][Full Text] [Related]
34. Capsular K1 polysaccharide of Escherichia coli: relationship to virulence in newborn rats and resistance to phagocytosis.
Bortolussi R; Ferrieri P; Björkstén B; Quie PG
Infect Immun; 1979 Jul; 25(1):293-8. PubMed ID: 383617
[TBL] [Abstract][Full Text] [Related]
35. The effects of capsular polysaccharide on the capacity of serum to support the killing of type 3 Streptococcus pneumoniae by human neutrophils.
Esposito AL; Clark CA
APMIS; 1990 Sep; 98(9):812-22. PubMed ID: 2171581
[TBL] [Abstract][Full Text] [Related]
36. Effects of pneumococcal mucopeptide and capsular polysaccharide on phagocytosis.
Dhingra RK; Williams RC; Reed WP
Infect Immun; 1977 Jan; 15(1):169-74. PubMed ID: 13039
[TBL] [Abstract][Full Text] [Related]
37. The biochemistry of opsonization: central role of the reactive thiolester of the third component of complement.
Hostetter MK; Krueger RA; Schmeling DJ
J Infect Dis; 1984 Nov; 150(5):653-61. PubMed ID: 6491376
[TBL] [Abstract][Full Text] [Related]
38. Effect of immune globulin intravenous on opsonization of bacteria by classic and alternative complement pathways in premature serum.
Shaio MF; Yang KD; Bohnsack JF; Hill HR
Pediatr Res; 1989 Jun; 25(6):634-40. PubMed ID: 2662129
[TBL] [Abstract][Full Text] [Related]
39. Opsonization of four Bacteroides species: role of the classical complement pathway and immunoglobulin.
Tofte RW; Peterson PK; Schmeling D; Bracke J; Kim Y; Quie PG
Infect Immun; 1980 Mar; 27(3):784-92. PubMed ID: 6103873
[TBL] [Abstract][Full Text] [Related]
40. Aging reduces the functionality of anti-pneumococcal antibodies and the killing of Streptococcus pneumoniae by neutrophil phagocytosis.
Simell B; Vuorela A; Ekström N; Palmu A; Reunanen A; Meri S; Käyhty H; Väkeväinen M
Vaccine; 2011 Feb; 29(10):1929-34. PubMed ID: 21236231
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
